| Line Item | 2025-12-26 | Y/Y |
|---|---|---|
| Revenue | $2.05B | -2.1% |
| Cost of Revenue | $1.73B | -0.6% |
| Gross Profit | $322.9M | -9.4% |
| R&D Expense | $32.0M | +13.1% |
| SG&A Expense | $186.0M | +3.6% |
| Operating Income | -$107.4M | -217.8% |
| Pre-tax Income | -$145.7M | -316.8% |
| Income Tax | $25.9M | -20.8% |
| Net Income | -$181.2M |
| Line Item | 2025-12-26 | Y/Y |
|---|---|---|
| Cash & Equivalents | $311.8M | -0.7% |
| Accounts Receivable | $208.8M | -13.4% |
| Inventory | $390.9M | +2.6% |
| Current Assets | $959.7M | -1.1% |
| Total Assets | $1.73B | -9.9% |
| Current Liabilities | $300.7M | -10.4% |
| Long-term Debt | $481.4M | -3.7% |
| Line Item | 2025-12-26 | Y/Y |
|---|---|---|
| Operating Cash Flow | $65.6M | +0.9% |
| Capital Expenditures | $50.3M | -20.8% |
| Investing Cash Flow | -$47.0M | +26.0% |
| Financing Cash Flow | -$21.2M | -316.3% |
| Free Cash Flow | $15.3M | +920.0% |
| -864.6% |
| EPS (Basic) | -$4.00 | -854.7% |
| EPS (Diluted) | -$4.00 | -869.2% |
| Total Liabilities |
| $944.9M |
| -4.0% |
| Stockholders' Equity | $711.0M | -18.6% |